Veracyte share price logo

Veracyte

NASDAQ: VCYT

Mid Cap

$43.12

-1.27

(-2.86%)

as on

Veracyte Stock Performance

as on October 17, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $42.90
    $45.75
    downward going graph

    0.51%

    Downside

    6.10%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $29.46
    $60.91
    downward going graph

    31.69%

    Downside

    41.26%

    Upside

    downward going graph

Veracyte share price movements today

Previous Close
$44.39
Open
$44.97
Volume
947.6K
Market Cap
$3.6B
Day's Low - High
$42.90 - $45.75
52 Week Low - High
$29.46 - $60.91

Veracyte Historical Returns

1 Month Return
+ 6.29 %
3 Month Return
-27.08 %
1 Year Return
+ 20.35 %
3 Year Return
+ 100.37 %
5 Year Return
-4.52 %

Veracyte Stock Fundamentals & Key Indicators

Check Veracyte market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.6B

EPS (TTM)

1.44

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

2.89%

PE Ratio (TTM)

30.83

Industry PE ratio

45.09

PEG Ratio

0.10

EBITDA

129.8M

Revenue (TTM)

561.9M

Profit Margin

72.09%

Return On Equity TTM

8.64%

Veracyte vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Veracyte with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Veracyte image
Veracyte
Buy$3.6B-4.52%30.8372.09%0.00%
Natera image
Natera
StrongBuy$56.9B265.43%-290.2665.30%0.00%
Agilent image
Agilent
StrongBuy$49.1B12.85%34.4953.73%0.58%
Thermo Fisher image
Thermo Fisher
StrongBuy$248.9B18.48%37.4141.03%0.26%
Danaher image
Danaher
StrongBuy$158.0B-24.00%39.7758.51%0.66%

Stock Returns calculator for Veracyte Stock including INR - Dollar returns

The Veracyte stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Veracyte investment value today

Current value as on today

₹1,30,049

Returns

₹30,049

(+30.05%)

Returns from Veracyte Stock

₹20,346 (+20.35%)

Dollar Impact

₹9,703 (+9.7%)

Analyst Recommendation on Veracyte Stock

Based on 8 analysts

BUY

75.00%

Buy

12.50%

Hold

12.50%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Veracyte. Average target price of $58.42

Veracyte Share Price Target

Get share price movements and forecasts by analysts on Veracyte.

What analysts predicted

26.19%UPSIDE

Target Price

$58.42

Current Price

$43.12

Analyzed by

8 Analysts

High

$69

Target

$58.42

Low

$44

Veracyte target price $58.42, a slight upside of 26.19% compared to current price of $43.12. According to 8 analysts rating.

Indian Investors' Interest in Veracyte Stock

Search interest for Veracyte Stock has increased by 151% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:151% versus previous 30 day period

Veracyte Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
96
114
115
118
114
130
131
140
139
150
Gross Profit
62
77
79
78
79
89
91
104
100
108
Operating Income
-4
4
12
4
2
-5
22
25
23
22
EBITDA
1
13
22
9
6
6
24
45
35
24
Interest Expense
-
0
0
-
-
-
-
-
-
-
Depreciation
5
5
5
6
5
5
5
5
5
4
Income Before Tax
-1
7
16
3
7
1
18
40
29
19
Income Tax Expense
0
1
1
-1
0
2
0
0
1
-6
Net Income
-1
5
15
5
7
0
19
41
28
25
Net Profit Margin
64.50%
68.09%
68.19%
66.39%
69.46%
68.97%
69.22%
74.43%
72.32%
72.21%

Veracyte Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
71
92
120
117
219
296
361
445
517
Gross Profit
43
58
83
76
145
194
248
298
360
Operating Income
-26
-22
-15
-35
-81
-41
-85
16
74
EBITDA
-23
-17
-7
-26
-61
-10
-49
49
89
Interest Expense
4
1
0
0
0
0
0
0
-
Depreciation
3
3
4
7
19
25
27
23
21
Income Before Tax
-31
-22
-12
-34
-81
-36
-76
25
68
Income Tax Expense
-
-
-
-
-6
0
-2
1
1
Net Income
-31
-22
-12
-34
-75
-36
-74
24
66
Net Profit Margin
60.81%
64.05%
69.66%
64.71%
66.11%
65.74%
68.73%
66.88%
69.62%

Veracyte Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
5
15
5
7
0
19
49
28
25
Operating Cash Flow
-8
29
29
24
5
33
44
52
35
45
Investing Cash Flow
2
-2
-2
-54
-51
0
48
-5
-127
-13
Financing Cash Flow
0
0
10
-4
-6
0
2
0
-6
4
Change in Cash
-7
26
38
-34
-52
33
96
47
-99
36

Veracyte Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-31
-22
-12
-34
-75
-36
-74
24
66
Operating Cash Flow
-23
-13
-3
-9
-31
7
44
75
136
Investing Cash Flow
-1
-1
-42
-3
-739
-29
15
-56
-9
Financing Cash Flow
0
59
127
203
596
3
2
4
-4
Change in Cash
-25
44
81
190
-176
-18
62
23
123

Global Institutional Holdings in Veracyte

Check out the Institutions with significant holdings in Veracyte.

Funds
Holdings
iShares
12.30%
Vanguard
9.49%
VANGUARD INDEX FUNDS
7.77%
SPDR
4.94%
ARK
4.02%
See all

Veracyte News & Key Events

  • img

    Today's Timeline - 07 October

    Wed, 06:21 PM

    -

    Veracyte reports Q2 2026 EPS of 54 cents, beating estimates by 25.6% and revenues of $150.3 million, exceeding expectations.

Insights on Veracyte

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, VCYT stock has moved up by 8.4%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 139.07M → 150.32M (in $), with an average increase of 7.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Natera, Inc. Common Stock has given 839.4% return, outperforming this stock by 731.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Natera, Inc. Common Stock has given 116.5% return, outperforming this stock by 96.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 41.14M → 25.48M (in $), with an average decrease of 20.7% per quarter

About Veracyte

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
OrganisationVeracyte
Headquarters6000 Shoreline Court, South San Francisco, CA, 94080, US
IndustryMedical - Diagnostics & Research
CEOMarc Stapley

Key Management of Veracyte

Name

Title

Mr. Jonathan Wygant

VP & Chief Accounting Officer

Mr. Marc A. Stapley

CEO & Director

Ms. Rebecca Chambers

Executive VP & CFO

Dr. Phillip G. Febbo M.D.

Chief Scientific & Medical Officer

Dr. John Leite Ph.D.

Global Chief Commercial Officer

Dr. Keith Gligorich Ph.D.

Senior Vice President of Global Operations

Ms. Annie McGuire

Executive VP, General Counsel & Head of Market Access

Dr. Kevin Richard Haas Ph.D.

Chief Development & Technology Officer

Mr. Steven French

Senior VP & Chief Information Officer

Ms. Kelly Gura

Director of Investor Relations

FAQs

What is Veracyte share price today?

Veracyte share price today is $43.12 as on at the close of the market. Veracyte share today touched a day high of $45.75 and a low of $42.90.

What is the 52 week high and 52 week low for Veracyte share?

Veracyte share touched a 52 week high of $60.91 on and a 52 week low of $29.46 on . Veracyte stock price today i.e. is closed at $43.12,which is 29.21% down from its 52 week high and 46.39% up from its 52 week low.

What is Veracyte's market capitalisation today?

Veracyte market capitalisation is $0.00T as on .

How to invest in Veracyte Stock (VCYT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Veracyte on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Veracyte Stock (VCYT) from India?

Indian investors can start investing in Veracyte (VCYT) shares with as little as ₹94.959999084473 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Veracyte stock (as per the Rupee-Dollar exchange rate as on ). Based on Veracyte share’s latest price of $43.12 as on October 17, 2026 at 8:45 am IST, you will get 0.2319 shares of Veracyte. Learn more about fractional shares .

What are the returns that Veracyte has given to Indian investors in the last 5 years?

Veracyte stock has given -4.52% share price returns and 26.39% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?